KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares Outstanding
Ratios

Organon (OGN) Leases (2020 - 2025)

Organon has reported Leases over the past 6 years, most recently at $155.0 million for Q4 2025.

  • For Q4 2025, Leases fell 1.27% year-over-year to $155.0 million; the TTM value through Dec 2025 reached $155.0 million, down 1.27%, while the annual FY2025 figure was $155.0 million, 1.27% down from the prior year.
  • Leases for Q4 2025 was $155.0 million at Organon, down from $157.0 million in the prior quarter.
  • Over five years, Leases peaked at $293.0 million in Q2 2021 and troughed at $155.0 million in Q4 2025.
  • A 5-year average of $215.9 million and a median of $215.0 million in 2022 define the central range for Leases.
  • Biggest five-year swings in Leases: soared 641.94% in 2021 and later decreased 19.53% in 2023.
  • Year by year, Leases stood at $230.0 million in 2021, then decreased by 6.52% to $215.0 million in 2022, then decreased by 19.53% to $173.0 million in 2023, then decreased by 9.25% to $157.0 million in 2024, then fell by 1.27% to $155.0 million in 2025.
  • Business Quant data shows Leases for OGN at $155.0 million in Q4 2025, $157.0 million in Q4 2024, and $173.0 million in Q4 2023.